Pharmaceuticals

Large Study Confirms Topical Glaucoma Meds, CME Association

Mainstay drugs trigger inflammatory mediators that lead to edema.
05/17/2018

Visual Gains Lost After AMD Trial

Positive study results fail to translate into the real-world outcomes as AMD patients become less careful about their follow-up care.
05/16/2018

Managing Uveitis With Steroids and Biologic Agents

The latest developments for this condition are based on underlying immunologic mechanisms. Here’s what that means for your practice.
05/15/2018

Identified: Meds That Worsen Dry Eye

Glaucoma drugs are likely culprits, plus antidepressants, GI therapies and more.
05/04/2018

Aerie Rolls Out Rhopressa

New glaucoma agent is in drugstores now, the company says.
04/30/2018

Off-Label Avastin Saved US at Least $17 Billion

The doctor who created this phenomenon looks back on his handiwork.
04/27/2018

Sustained Glaucoma Treatment Acceptable, Patients Say

…but only if it eliminates surgery or works better than drops.
04/24/2018

Scleritis New Target of Iontophoretic Drug Delivery

This novel approach could improve results of dexamethasone therapy.
04/20/2018

Ocular Insert: A Step Toward Dropping Drops

New delivery method may bypass patient compliance with topical therapy.
04/20/2018

Sizing Up Anti-inflammatories in Dry Eye Disease

A practical guide for optometrists applying these medications.
04/15/2018

Upcoming Events

November 2-4, 2018

New Technologies & Treatments in Eye Care Arlington
Location:
 The Westin Arlington Gateway
Program Chair: Paul Karpecki, OD, FAAO
Up to 19 CE credits (COPE approval pending)
Register here

Jobs

Jobs Powered By Local Eye Site